Researcher interests: Eating disorders and eating regulation. Anorexia. Body weight regulation; development of therapeutic devices for treating anorexia nervosa. Leptin as a survival hormone. Endocannabinoids for the treatment of eating disorders. Liver disease, hepatic encephalopathy and diabetic neuropathy. Animal models for treating obesity and diabetes. Development of therapeutic devices for the treatment of weight loss and depression associated with the metabolic syndrome. Leptin, neurogenesis and angiogenesis in stroke. Postpartum depression. Steatosis and CVD. Prevention of autism by retinoids supplementation. Development of functional foods against Alzheimer`s disease.
FACULTY / SCHOOL: School of Medicine - IMRIC

Selected Publications

Leptin Reduces Infarct Size in Association with Enhanced Expression of CB2, TRPV1, SIRT-1 and Leptin Receptor (2010)| Bentham Science Publishers| Read more
Cannabidiol ameliorates cognitive and motor impairments in mice with bile duct ligation☆ (2009)| ScienceDirect | Read more
Cannabinoids and Capsaicin Improve Liver Function Following Thioacetamide-Induced Acute Injury in Mice (2008)| AJG The American Journal Of GASTROENTEROLOGY| Read more

Contact for more information:

Shani Bullock
VP, Business Development, Healthcare
+972-2-6586608
Contact ME: